Investigations have revealed that activation of PPARγ in prostate cancer cells increased mitochondrial biogenesis and ATP levels by upregulating AKT3, which enhanced the nuclear localization of PGC1α [50,51]. The gene discussed is PPARG; the disease is prostate carcinoma.